au-409
Small moleculeexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Mar 29, 2023 (NCT05791448)
Timeline
2020s
- Jan 1, 2023
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06374485 | Phase 1 | Apr 12, 2024 | Lee's Pharmaceutical |
| NCT05791448 | Phase 1 | Mar 29, 2023 | National Cancer Institute (NCI), University of Southern California |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Lee's Pharmaceutical | For profit | 1 | 1 | 1 | 2024 |
| National Cancer Institute (NCI) | Government | 1 | 0 | 1 | 2023 |
| University of Southern California | Academic/Hospital | 1 | 1 | 1 | 2023 |
3 organizations
Page 1 / 1